180 Life Sciences Corp (ATNF)
2.00
+0.01
(+0.50%)
USD |
NASDAQ |
May 02, 16:00
2.00
0.00 (0.00%)
Pre-Market: 09:08
180 Life Sciences Total Liabilities (Quarterly): 5.387M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.387M |
| September 30, 2023 | 5.107M |
| June 30, 2023 | 6.951M |
| March 31, 2023 | 7.782M |
| December 31, 2022 | 8.306M |
| September 30, 2022 | 8.261M |
| June 30, 2022 | 10.57M |
| Date | Value |
|---|---|
| March 31, 2022 | 18.77M |
| December 31, 2021 | 23.39M |
| September 30, 2021 | 27.93M |
| June 30, 2021 | 53.55M |
| March 31, 2021 | 37.40M |
| December 31, 2020 | 25.25M |
| December 31, 2019 | 13.31M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.107M
Minimum
Sep 2023
53.55M
Maximum
Jun 2021
18.00M
Average
11.94M
Median
Total Liabilities (Quarterly) Benchmarks
| Seelos Therapeutics Inc | 38.93M |
| Altimmune Inc | 16.54M |
| GT Biopharma Inc | 6.633M |
| Outlook Therapeutics Inc | 46.03M |
| MAIA Biotechnology Inc | 7.089M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.260M |
| Shareholders Equity (Quarterly) | -0.1277M |